[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Serina Therapeutics Inc (SER)

Serina Therapeutics Inc (SER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Serina Therapeutics Inc 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 USA

https://serinatherapeutics.com Employees: 16 P: 256-327-9630

Sector:

Medical

Description:

Serina Therapeutics Inc. is a privately-held, clinical-stage biotechnology company developing a pipeline of therapies for the treatment of Parkinson's Disease and other neurological diseases. Serina Therapeutics Inc., formerly known as AgeX Therapeutics Inc., is based in HUNTSVILLE, Ala.

Key Statistics

Overview:

Market Capitalization, $K 29,696
Enterprise Value, $K 34,526
Shares Outstanding, K 14,998
Float, K 12,448
% Float 83.00%
Short Interest, K 294
Short Float 1.96%
Days to Cover 4.06
Short Volume Ratio 0.44
% of Insider Shareholders 17.00%
% of Institutional Shareholders 12.50%

Financials:

Annual Sales, $ 130 K
Annual Net Income, $ -19,180 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,900 K
EBIT, $ -24,450 K
EBITDA, $ -24,320 K

Growth:

1-Year Return -66.38%
3-Year Return -87.63%
5-Year Return -95.63%
5-Year Revenue Growth -93.05%
5-Year Earnings Growth 81.29%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.58 on 05/14/26
Next Earnings Date 08/10/26
Earnings Per Share ttm -2.00
EPS Growth vs. Prev Qtr -87.10%
EPS Growth vs. Prev Year -18.37%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 7-250 on 03/15/24

SER Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -8,051.54%
Return-on-Assets % -155.08%
Profit Margin % -14,753.85%
Debt/Equity 0.17
Price/Sales 217.70
Price/Cash Flow N/A
Price/Book 2.22
Book Value/Share 1.18
Interest Coverage -90.43
60-Month Beta 1.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.